Skip to main content
  1. News
  2. Top News

New painkiller: Lethal potential in painkiller about to be released

See also

A new painkiller set to be released in March is worrying doctors and addiction experts because of its extreme potency. In fact, they are pressuring the the Food and Drug Administration (FDA) to revoke their approval of the prescription drug and not make it available, NewsMax reports Feb. 27.

Zohydro is an opioid drug made by Zogenix Inc. in San Diego. The painkiller contains an abundnant amount of opioid analgesics -- which could be fatal to children and new patients,doctors and experts say.

"In the midst of a severe drug epidemic fueled by overprescribing of opioids, the very last thing the country needs is a new, dangerous, high-dose opioid," those opposed to the new painkiller wrote in a letter to FDA Commissioner Dr. Margaret Hamburg.

"Too many people have already become addicted to similar opioid medications, and too many lives have been lost," the letter continued.

Zohydro is a medication that was approved in October 2013 by the FDA to aid in relieving patients suffering intolerable pain and who need "daily, around-the-clock, long-term treatment." The intention was for this drug to do what all other pain relievers could not in extreme cases.

"It's a Dr. Andrew Kolodny, who is president of the advocacy group Physicians for Responsible Opioid Prescribing, said the pill's ingredient is a "whopping dose of hydrocodone packed in an easy-to-crush capsule." He said it "will kill people as soon as it's released."

The new painkiller is reportedly five times more potent than the strongest prescription medicine on the market now.

The pill's maker, Zogenix, rates the drug as having more advantages than disadvantages.

"We do not expect the introduction of Zohydro ER (extended release) to increase the overall use of opioids," said Dr. Brad Galer -- executive vice president and chief medical officer at Zogenix. "In fact, prescription data from the last five years shows that total use of ER opioids is constant and independent of new entrants to the market."

The FDA will review the letter submitted by activists against Zohydro's release.

Despite the troubling crisis of drug addictions and deaths associated with strong prescription medication, there are those who are terminally ill and the discomfort is unimaginable. If there is a drug that can make life less miserable, approval of a drug like this could make all the difference for them. Arguments for and against are all true, but ultimately people have to be responsible for what they put into their bodies. The new painkiller has drawn some debate and it will be interesting to see what the FDA decides.

Copyright © 2014 Heather Tooley

Heather focuses on trending news and entertainment headlines. To read more from this writer, her Twitter page is @HotTopicWriter or hit the "Subscribe" at the beginning of the article above.



  • Mt. Everest avalanche
    Disaster strikes Mt. Everest as at least 12 people were killed in an avalanche
    Watch Video
  • Most Earthlike planet discovered
    The Kepler telescope has discovered the most Earthlike, possibly habitable planet yet
    Space News
  • Easter crosses create debate
    Easter crosses spark a debate of separation of church and state in Ohio
  • Chelsea Clinton is preggers
    Former first daughter Chelsea Clinton is pregnant with her first child
  • Stanley Cup playoffs
    The battle for Lord Stanley's Cup is on, don't miss a minute of playoff action
  • Ukraine discussed amongst U.S., E.U., Russia
    The U.S., E.U. and Russia agree on ways to diffuse the tension in Ukraine
    Watch Video

Related Videos:

  • Family members of missing ferry passengers refuse to let them rise the ferry with cranes.
    <div class="video-info" data-id="517902149" data-param-name="playList" data-provider="5min" data-url=""></div>
  • Lindsay Lohan
    <div class="video-info" data-id="518157378" data-param-name="playList" data-provider="5min" data-url=""></div>
  • Target stores open or closed on Easter Sunday 2014?
    <div class="video-info" data-id="517757176" data-param-name="playList" data-provider="5min" data-url=""></div>

User login

Log in
Sign in with your email and password. Or reset your password.
Write for us
Interested in becoming an Examiner and sharing your experience and passion? We're always looking for quality writers. Find out more about and apply today!